Royal Marsden partnership to create state-of-the-art in-house liquid biopsy testing facility Read more Patients with cancer have low protection against the Delta variant but will benefit from a third dose of COVID-19 vaccine Read more here Targeted prostate cancer screening could benefit men with inherited cancer syndrome Read morePreviousNext Highlights Research is key to future treatment Our six research themes and two cross-cutting themes bring together a critical mass of internationally renowned clinicians, scientists and allied health professionals, allowing us to ensure that novel diagnostics and physical and systemic therapies are rapidly available to all cancer patients. Patient and public involvement and engagement Involving patients and the public with our research ensures that we focus on the issues that matter most to those affected by cancer. Find out more Latest news ICR and The Royal Marsden researchers named among world's most influential scientists Six researchers at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, have been named in a list of the world's most influential and innovative researchers over the last decade. Find out more Scientists identify potential new drug combination for children with incurable brain cancer Combining two existing cancer drugs could offer promise for some children with an incurable childhood brain cancer, a new study suggests. Find out more Consultant at The Royal Marsden appointed as the NIHR's national cancer lead for screening, prevention and early detection Dr Richard Lee, Consultant Respiratory Physician and Champion for Early Cancer Diagnosis at The Royal Marsden NHS Foundation Trust, has been appointed as the NIHR's national cancer lead for screening, prevention and early detection. Find out more More information Upcoming events BRC training hub Magazine articles Follow us on Twitter
